OAG
CLBT icon

Orbis Allan Gray’s Cellebrite CLBT Stock Holding History

Orbis Allan Gray’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
+1,707,749
New +$22.6M 0.09% 84
2026
Q1 		– Sell
-670,613
Closed -$12.1M – 93
2025
Q4 		$12.1M Buy
670,613
+154,114
+30% +$2.77M 0.05% 85
2025
Q3 		$9.57M Buy
+516,499
New +$8.11M 0.04% 82

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Orbis Allan Gray's CLBT Position: Q2 2026 in Review

Orbis Allan Gray opened a new position in Cellebrite (CLBT) in Q2 2026: 1,707,749 shares worth $24.9M. The stake represents 0.09% of the portfolio and ranks #84 among its holdings. This is a return to the name: Orbis Allan Gray previously reported a position in CLBT as recently as Q4 2025.

Orbis Allan Gray first reported a position in CLBT in Q3 2025 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Orbis Allan Gray held 1,707,749 shares of Cellebrite worth $24.9M as of Q2 2026.
  • Cellebrite was a new Orbis Allan Gray position in Q2 2026.
  • Cellebrite made up 0.09% of Orbis Allan Gray's portfolio in Q2 2026, its #84 holding.
  • Orbis Allan Gray first reported a position in Cellebrite in Q3 2025 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Orbis Allan Gray's 13F filing for Q2 2026, filed 14 Aug 2026.